The Effect of on Cytotoxicity and Apoptosis Induced by Typhimurium in HT-29 Cell Culture

Overview

Journal Iran J Microbiol

Publisher Tehran University of Medical Sciences

Specialty Infectious Diseases

Date 2019 Nov 14

PMID 31719962

Citations 4

Authors

Amin Kawarizadeh

Farshad Nojoomi

Mohammad Tabatabaei

Saeid Hosseinzadeh

Mina Farzaneh

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Human epithelial cells have been widely used to study the interaction between intestinal cells and pathogens, . In this study, the effect of probiotic bacteria and its supernatant on the growth inhibition, cytotoxicity and induction of apoptosis caused by Typhimurium and its adhesion to HT-29 cells were investigated.

Materials And Methods: supernatant was used to obtain the minimum inhibitory concentration. To evaluate the cytotoxicity and percent of apoptotic cells, and its supernatant (2, 4, 6 and 8% concentrations) with Typhimurium was added to HT-29 cells. The MTT assay was used in order to evaluate the cytotoxicity. Percent of apoptotic cells was reported using a fluorescence staining method. Additionally, the adhesion of Typhimurium to HT-29 cells was investigated. The effect of on the level of adhesion was also studied.

Results: The most inhibitory effect was shown at the concentration of 80000 μg/ml supernatant of (54.77% ± 1.43). The simultaneous culture of Typhimurium with had the lowest amount of cytotoxicity and induced apoptosis among the all co-culture groups of Typhimurium with or its supernatant. The determined cytotoxicity and induced apoptosis were 26.06 % ± 3.79 and 17.63 % ± 2.14 respectively. In the adhesion test, it was observed that can significantly prevent adhesion of Typhimurium to HT-29 cell.

Conclusion: can reduce the adhesion, cytotoxicity and induction of apoptosis caused by Typhimurium in HT-29 cells

Citing Articles

Isolation and Identification of Effective Probiotics on Drug-Resistant Strains and Their Biofilms.

Abbasi Z, Ghasemi S, Ahmadi Y, Shokri D Can J Infect Dis Med Microbiol. 2024; 2024:8570521.

PMID: 38440403 PMC: 10911883. DOI: 10.1155/2024/8570521.

The Game for Three: -Host-Microbiota Interaction Models.

Grzymajlo K Front Microbiol. 2022; 13:854112.

PMID: 35516427 PMC: 9062650. DOI: 10.3389/fmicb.2022.854112.

Inhibitory effects of probiotic against MCF7 breast cancer cells.

Dolati M, Tafvizi F, Salehipour M, Komeili Movahed T, Jafari P Iran J Microbiol. 2022; 13(6):839-847.

PMID: 35222863 PMC: 8816703. DOI: 10.18502/ijm.v13i6.8089.

Interaction between the probiotic and Typhimurium in Caco-2 cell culture.

Ostovan R, Pourmontaseri M, Hosseinzadeh S, Shekarforoush S Iran J Microbiol. 2021; 13(1):91-97.

PMID: 33889367 PMC: 8043819. DOI: 10.18502/ijm.v13i1.5497.

References

Behzad S, Ebrahim K, Mosaddegh M, Haeri A . Primula auriculata Extracts Exert Cytotoxic and Apoptotic Effects against HT-29 Human Colon Adenocarcinoma Cells. Iran J Pharm Res. 2016; 15(1):311-22. PMC: 4986124. View

McClelland M, Sanderson K, Spieth J, Clifton S, Latreille P, Courtney L . Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001; 413(6858):852-6. DOI: 10.1038/35101614. View

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

Bomko T, Nosalskaya T, Kabluchko T, Lisnyak Y, Martynov A . Immunotropic aspect of the Bacillus coagulans probiotic action. J Pharm Pharmacol. 2017; 69(8):1033-1040. DOI: 10.1111/jphp.12726. View

Kawarizadeh A, Tabatabaei M, Hosseinzadeh S, Farzaneh M, Pourmontaseri M . The effects of probiotic Bacillus coagulans on the cytotoxicity and expression of alpha toxin gene of Clostridium perfringens type A. Anaerobe. 2019; 59:61-67. DOI: 10.1016/j.anaerobe.2019.05.008. View

Servin A . Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28(4):405-40. DOI: 10.1016/j.femsre.2004.01.003. View

Martirani L, Varcamonti M, Naclerio G, De Felice M . Purification and partial characterization of bacillocin 490, a novel bacteriocin produced by a thermophilic strain of Bacillus licheniformis. Microb Cell Fact. 2002; 1(1):1. PMC: 115367. DOI: 10.1186/1475-2859-1-1. View

Pascual M, Hugas M, Badiola J, Monfort J, Garriga M . Lactobacillus salivarius CTC2197 prevents Salmonella enteritidis colonization in chickens. Appl Environ Microbiol. 1999; 65(11):4981-6. PMC: 91670. DOI: 10.1128/AEM.65.11.4981-4986.1999. View

Bermudez-Brito M, Plaza-Diaz J, Fontana L, Munoz-Quezada S, Gil A . In vitro cell and tissue models for studying host-microbe interactions: a review. Br J Nutr. 2013; 109 Suppl 2:S27-34. DOI: 10.1017/S0007114512004023. View

10.

Schoster A, Kokotovic B, Permin A, Pedersen P, Dal Bello F, Guardabassi L . In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe. 2013; 20:36-41. DOI: 10.1016/j.anaerobe.2013.02.006. View

11.

Cazorla S, Maldonado-Galdeano C, Weill R, De Paula J, Perdigon G . Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity. Front Microbiol. 2018; 9:736. PMC: 5911494. DOI: 10.3389/fmicb.2018.00736. View

12.

Golowczyc M, Mobili P, Garrote G, Abraham A, De Antoni G . Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis. Int J Food Microbiol. 2007; 118(3):264-73. DOI: 10.1016/j.ijfoodmicro.2007.07.042. View

13.

Casey J, OCleirigh C, Walsh P, OShea D . Development of a robust microtiter plate-based assay method for assessment of bioactivity. J Microbiol Methods. 2004; 58(3):327-34. DOI: 10.1016/j.mimet.2004.04.017. View

14.

Morishita T, Aye P, Harr B, Cobb C, Clifford J . Evaluation of an avian-specific probiotic to reduce the colonization and shedding of Campylobacter jejuni in broilers. Avian Dis. 1998; 41(4):850-5. View

15.

Teo A, Tan H . Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens. Appl Environ Microbiol. 2005; 71(8):4185-90. PMC: 1183296. DOI: 10.1128/AEM.71.8.4185-4190.2005. View

16.

Honda H, Gibson G, Farmer S, Keller D, McCartney A . Use of a continuous culture fermentation system to investigate the effect of GanedenBC30 (Bacillus coagulans GBI-30, 6086) supplementation on pathogen survival in the human gut microbiota. Anaerobe. 2011; 17(1):36-42. DOI: 10.1016/j.anaerobe.2010.12.006. View

17.

Shreiner A, Kao J, Young V . The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2014; 31(1):69-75. PMC: 4290017. DOI: 10.1097/MOG.0000000000000139. View

18.

Thirabunyanon M, Thongwittaya N . Protection activity of a novel probiotic strain of Bacillus subtilis against Salmonella Enteritidis infection. Res Vet Sci. 2011; 93(1):74-81. DOI: 10.1016/j.rvsc.2011.08.008. View

19.

Maathuis A, Keller D, Farmer S . Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine. Benef Microbes. 2011; 1(1):31-6. DOI: 10.3920/BM2009.0009. View

20.

Corthesy B, Gaskins H, Mercenier A . Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007; 137(3 Suppl 2):781S-90S. DOI: 10.1093/jn/137.3.781S. View